Clinical Trial: Circadian as A Prognostic Factor For Radiation Response in Cervical Cancer
Study Status: Completed
Recruit Status: Completed
Condition:
Cervical Cancer
Radiotherapy Side Effect
Study Type: Interventional
Official Title: Influence of Radiation Patterns Following Circadian Rhythm Upon Response of Radiotherapy of Uterine Cervical Cancer : Melatonin as a Radiosensitivity and Biological Marker
Brief Summary:
The study was a Randomized Clinical Trial (RCT) or clinical trial comparing the results of radiation treatment of 2 treatment groups, i.e. subject groups irradiated in the morning and in the afternoon, to check melatonin levels in cervical cancer patients. Since it is known that the function of melatonin is as an antiproliferation substance or hormone, induces apoptosis, inhibits invasion and metastasis.
Read more